secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0000064803-24-000006
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Q4 revenue $93.8B (+11.9% YoY), adj. EPS $2.12; FY2024 adj. EPS guidance cut to $8.30
--------------------------------------------------------------------------------

- Q4 total revenues $93.8B (+11.9% YoY); GAAP diluted EPS $1.58, adjusted EPS $2.12.
- Full-year 2023 revs $357.8B (+10.9%), GAAP EPS $6.47, adj. EPS $8.74; ops cash flow $13.4B.
- FY2024 guidance revised: adj. EPS at least $8.30 (from $8.50), GAAP EPS at least $7.06, ops cash flow $12.0B.
- Quarterly dividend raised 10% effective Feb 1, 2024; $3.1B returned via dividends in 2023.
- Launched CVS CostVantage, Caremark TrueCost pricing models and CVS Healthspire segment for 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000006/0000064803-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000006/cvs-20240207.htm
  HTML page:      https://secwatch.observer/filing/0000064803-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer